Prescription drug · NDA
Zoladex (Goserelin) NDC 70720-951
Goserelin acetate 10.8 mg/1 · Implant · Subcutaneous · TerSera Therapeutics LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70720-951-30 | 70720095130 | 1 POUCH in 1 CARTON (70720-951-30) / 1 SYRINGE in 1 POUCH / 1 IMPLANT in 1 SYRINGEMarketed from Jan 26, 2018 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zoladex
- Generic name (nonproprietary)
- goserelin
- Active ingredients
- Goserelin acetate — 10.8 mg/1
- Dosage form
- Implant
- Route
- Subcutaneous
- Labeler
- TerSera Therapeutics LLCNDC labeler code 70720
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020578
- Marketing start
- Listing expires
- Other FDA classes
- Gonadotropin Releasing Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 70720-951_a7c38eaa-3f9a-4b24-8634-bdac6138f983SPL ID a7c38eaa-3f9a-4b24-8634-bdac6138f983SPL set ID e4cb3c20-2738-400a-b522-3f36f71fe6c5RxCUI 211544, 314008UNII 6YUU2PV0U8
- Pharmacologic class
- Gonadotropin Releasing Hormone Receptor Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470720095130followed by a unit qualifier and the quantityPackage 70720-0951-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for: Use in combination with flutamide for the management of locally confined carcinoma of the prostate ( 1.1 ) Use as palliative treatment of advanced carcinoma of the prostate ( 1.2 ) 1.1 Stage B2-C Prostatic Carcinoma ZOLADEX is indicated for use in combination with flutamide for the management of locally confined Stage T2b-T4 (Stage B2-C) carcinoma of the prostate. Treatment with ZOLADEX and flutamide should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy [see Dosage and Administration ( 2.1 ) and Clinical Studies ( 14.1 )]. 1.2 Prostatic Carcinoma ZOLADEX is indicated in the pa…
Excerpt only. Read the full label for complete information.
About NDC 70720-951
- What is NDC 70720-951?
- 70720-951 is the product NDC for Zoladex (goserelin), Goserelin acetate 10.8 mg/1 implant, listed with the FDA by TerSera Therapeutics LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zoladex (Goserelin).
- What is the active ingredient?
- Goserelin acetate.
- Who is the labeler?
- TerSera Therapeutics LLC, NDC labeler code 70720. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zoladex?
- 1 other product NDC are listed under this name. See all Zoladex NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zoladex products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zoladexgoserelin | Goserelin acetate 3.6 mg/1 | ImplantSubcutaneous | TerSera Therapeutics LLC | 70720-950 | 70720-0950-36 |